Cargando…
Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets
Breast cancer, comprising of several sub-phenotypes, is a leading cause of female cancer-related mortality in the UK and accounts for 15% of all cancer cases. Chemoresistant sub phenotypes of breast cancer remain a particular challenge. However, the rapidly-growing availability of clinical datasets,...
Autores principales: | Alnoumas, Layla, van den Driest, Lisa, Apczynski, Zoe, Lannigan, Alison, Johnson, Caroline H., Rattray, Nicholas J. W., Rattray, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364282/ https://www.ncbi.nlm.nih.gov/pubmed/35948941 http://dx.doi.org/10.1186/s12885-022-09969-4 |
Ejemplares similares
-
The Differential Metabolic Signature of Breast Cancer Cellular Response to Olaparib Treatment
por: Berardi, Domenica, et al.
Publicado: (2022) -
Integrative bioinformatics analysis of KPNA2 in six major human cancers
por: Xu, Chaobo, et al.
Publicado: (2021) -
Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7
por: Duan, Jihui, et al.
Publicado: (2017) -
Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7
por: Duan, Jihui, et al.
Publicado: (2016) -
Bile acid distributions, sex-specificity, and prognosis in colorectal cancer
por: Cai, Yuping, et al.
Publicado: (2022)